Prof. Gary E. Meyerrose

Department of Internal Medicine, Division of Cardiology

USA

Professor of Medicine

Email: gary.meyerrose@ttuhsc.edu

Qualifications

1975 M.D., University of Tennessee

1972 B.A., University of Tennessee

Publications (selected)

1. Irons B, Street R, Seifert C, Meyerrrose GE.  Factors associated with increased utilization n patients with heart failure and preserved ejection fraction.  Pharmacotherapy. July 2010
2. Tskiouris JP, PharmD; Cox CD, PharmD; Simoni JS, DVM; Seifert CF, PharmD; Peek MC, MS; Meyerrose GE, MD:  Lack of effect on coronary atherosclerotic disease biomarkers with modest dosing of an angiotensin-converting enzyme inhibitor, angiotensin II typw-1 receptor blocker, and the combination.  Coronary Artery Disease, August 2006.
3. Bradley JT, MD; Sutthiwat P, MD; Jenkins LA, MD; Meyerrose GE, MD: “Fixed Defect on Stress Myocardial Imaging Resulting From Previous Trauma Masquerading as Coronary Artery Disease”.  Clinical Nuclear Medicine, Vol 30 #6, June 2005.
4. Druback DA, Carmona S, Meyerrose GE, Peraltra LM, Sostre S.  ABrain SPECT in a Case of Cortical Blindness@Stroke, 1994; 25:1061-1064.
5. Irons BK, Trujillo A, Seifert CF, Simoni JS, Doctolero S. Meyerrose GE. Effects of Direct Renin Inhibition on Atherosclerotic Biomarkrs in Patients With Artery Disease and Type 2 Diabetes  Mellitus.  J Cardiovasc Pharmacol Ther. 2013 May 20. (Epub ahead of print)
6. Trujillo A, Soontrapa S. Singh P, Sehli S, Harris J, Suarez JA, Arvandi A, Paone RF, Meyerrose GE. Giant coronary artery aneurysm seen on blood-pool study. Clin Nucl Med. 2013 Jan:38(1):e43-4. Doi:10.1097/RLU.0b013e31824c5f8c.
7. Cevik C, Nugent k, Meyerrose G, Otahbachi M, Izgi C, Lyte M, Fish RD. Rosuvastatin therapy does not affect serum MMP-13 or TIMP-1 levels in hypercholesterolemic patients. Tex Heart Inst J. 2011;38(3):229-33.
8. Yaqub Y, Meyerrose GE, Harris J, Nugent K. Ectopic kidney on Technetium 99m SPECT imaging. TX Heart Inst J 2011;38(1):96-7.

Profile Details

Last Updated: July, 2013.